These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24533654)
1. Chemically synthesized matrix metalloproteinase and angiogenesis-inhibiting peptides as anticancer agents. Hu J; Yan M; Pu C; Wang J; Van den Steen PE; Opdenakker G; Xu H Anticancer Agents Med Chem; 2014 Mar; 14(3):483-94. PubMed ID: 24533654 [TBL] [Abstract][Full Text] [Related]
2. Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment. Qiu Z; Hu J; Xu H; Wang W; Nie C; Wang X Anticancer Drugs; 2013 Aug; 24(7):677-89. PubMed ID: 23652276 [TBL] [Abstract][Full Text] [Related]
3. Fusion Peptides CPU1 and CPU2 Inhibit Matrix Metalloproteinases and Protect Mice from Endotoxin Shock Within a Strict Time Window. Qiu Z; Zhang F; Gong C; Xu H; Hu J Inflammation; 2015 Dec; 38(6):2092-104. PubMed ID: 26111477 [TBL] [Abstract][Full Text] [Related]
4. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells. Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633 [TBL] [Abstract][Full Text] [Related]
5. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity. Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024 [TBL] [Abstract][Full Text] [Related]
6. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells. Chuang CH; Liu CH; Lu TJ; Hu ML Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407 [TBL] [Abstract][Full Text] [Related]
7. Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis. Sun C; Feng SB; Cao ZW; Bei JJ; Chen Q; Zhao WB; Xu XJ; Zhou Z; Yu ZP; Hu HY Cell Physiol Biochem; 2017; 41(6):2319-2332. PubMed ID: 28463834 [TBL] [Abstract][Full Text] [Related]
8. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion. Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088 [TBL] [Abstract][Full Text] [Related]
11. A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation. Romanchikova N; Trapencieris P; Zemītis J; Turks M J Enzyme Inhib Med Chem; 2014 Dec; 29(6):765-72. PubMed ID: 24246091 [TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells. Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities. Yu G; Li Z; Tang L; Xiong Q Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo. Yi JM; Bang OS; Kim NS BMC Complement Altern Med; 2015 Mar; 15():42. PubMed ID: 25887757 [TBL] [Abstract][Full Text] [Related]
15. Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells. Kim A; Ma JY Phytomedicine; 2019 Apr; 57():95-104. PubMed ID: 30668328 [TBL] [Abstract][Full Text] [Related]
16. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides]. Chen HM; Yan XJ; Wang F; Lin J; Xu WF Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394 [TBL] [Abstract][Full Text] [Related]
17. CS5931, a novel polypeptide in Ciona savignyi, represses angiogenesis via inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). Liu G; Liu M; Wei J; Huang H; Zhang Y; Zhao J; Xiao L; Wu N; Zheng L; Lin X Mar Drugs; 2014 Mar; 12(3):1530-44. PubMed ID: 24633253 [TBL] [Abstract][Full Text] [Related]
18. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways. Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148 [TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of angiogenesis by hydroalcoholic extract of oak (Quercus infectoria) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion. Yarani R; Mansouri K; Mohammadi-Motlagh HR; Mahnam A; Emami Aleagha MS Pharm Biol; 2013 Mar; 51(3):361-8. PubMed ID: 23137183 [TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells. Xing Y; Tu J; Zheng L; Guo L; Xi T Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]